Author(s): Lalu Muhammad Irham, Zalik Nuryana, Dyah Aryani Perwitasari, Yudha Rizky Nuari, Made Ary Sarasmita, Wirawan Adikusuma, Haafizah Dania, Rita Maliza, Rocky Cheung

Email(s): lalu Muhammad Irham ,

DOI: 10.52711/0974-360X.2023.00219   

Address: Lalu Muhammad Irham1*, Zalik Nuryana2, Dyah Aryani Perwitasari1, Yudha Rizky Nuari1, Made Ary Sarasmita5,6, Wirawan Adikusuma3, Haafizah Dania1, Rita Maliza4, Rocky Cheung7
1Faculty of Pharmacy, University of Ahmad Dahlan, Yogyakarta, 55164, Indonesia.
2Department of Islamic Education, Universitas Ahmad Dahlan, Yogyakarta 55191, Indonesia.
3Departement of Pharmacy, University of Muhammadiyah Mataram, Mataram, 83127, Indonesia.
4Biology Department, Faculty of Mathematics and Natural Sciences, Andalas University, Padang, West Sumatra, Indonesia.
5Department of Clinical Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
6Pharmacy Study Program, Faculty of Science and Mathematics, Udayana University, Bali, Indonesia.
7Department of Chemistry and Biochemistry, University of California, Los Angeles, USA.
*Corresponding Author

Published In:   Volume - 16,      Issue - 3,     Year - 2023

Background: Science of medicine in the post-genomic era has significantly enhanced the knowledge of human diseases. These advancements could shed light to the translation of these benefits into drug therapeutics. Drug repurposing is a strategy that plays a pivotal role to provide novel insights into disease biology and further drive drug discovery as the ultimate goal. Herein, the current study aimed to analyse the global trends of drug repurposing peer-review publications from 2003 until 2022. Methods: We retrieved 1.371 articles related to drug repurposing studies and used similar terms and keywords, including “drug repositioning”, “drug repurposing”, “drug reprofiling”, “drug reusing”, and “drug recycling”. Results: The number of drug repurposing publications has increased dramatically from 2003 through 2022. Besides, the most active country in publishing drug repurposing research is the United States, followed by China, India, the United Kingdom, and Italy, respectively. Meanwhile, the top five frequently used keywords are drug repurposing (n = 336), drug repositioning (n = 335), COVID-19 (n = 134), SARS-CoV-2 (n = 135), and molecular docking (n = 67). Conclusions: This study emphasizes the importance of conducting active research collaboration in drug repurposing and drug repositioning especially pertaining to the COVID-19 pandemic.

Cite this article:
Lalu Muhammad Irham, Zalik Nuryana, Dyah Aryani Perwitasari, Yudha Rizky Nuari, Made Ary Sarasmita, Wirawan Adikusuma, Haafizah Dania, Rita Maliza, Rocky Cheung. Worldwide Publication Trends of Drug Repurposing and Drug Repositioning in the Science of Medicine (2003-2022). Research Journal of Pharmacy and Technology 2023; 16(3):1333-1. doi: 10.52711/0974-360X.2023.00219

Lalu Muhammad Irham, Zalik Nuryana, Dyah Aryani Perwitasari, Yudha Rizky Nuari, Made Ary Sarasmita, Wirawan Adikusuma, Haafizah Dania, Rita Maliza, Rocky Cheung. Worldwide Publication Trends of Drug Repurposing and Drug Repositioning in the Science of Medicine (2003-2022). Research Journal of Pharmacy and Technology 2023; 16(3):1333-1. doi: 10.52711/0974-360X.2023.00219   Available on:

1.    Sirota, M., et al., Discovery and preclinical validation of drug indications using compendia of public gene expression data. Science Translational Medicine, 2011. 3(96): p. 96ra77.
2.    Hay, M., et al., Clinical development success rates for investigational drugs. Nature Biotechnology, 2014. 32(1): p. 40-51.
3.    Paul, S.M., et al., How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Review Drug Discovery, 2010. 9(3): p. 203-14.
4.    Ayyar, P. and U. Subramanian, Repurposing – second life for drugs. Pharmacia, 2022. 69(1): p. 51-59.
5.    Sahragardjoonegani, B., et al., Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997. Journal of Pharmaceutical Policy and Practice, 2021. 14(1): p. 3.
6.    Algra, A.M. and P.M. Rothwell, Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. The Lancet. Oncology, 2012. 13(5): p. 518-27.
7.    Goldstein, I., et al., Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. The New England Journal of Medicine, 1998. 338(20): p. 1397-404.
8.    Singh, T.U., et al., Drug repurposing approach to fight COVID-19. Pharmacological reports: PR, 2020. 72(6): p. 1479-1508.
9.    Muralidharan, N., et al., Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure & Dynamics, 2021. 39(7): p. 2673-2678.
10.    Pushpakom, S., et al., Drug repurposing: progress, challenges and recommendations. Nature Reviews. Drug Discovery, 2019. 18(1): p. 41-58.
11.    Langedijk, J., et al., Drug repositioning and repurposing: terminology and definitions in literature. Drug Discovery Today, 2015. 20(8): p. 1027-34.
12.    Jones, A.W., Forensic Journals: Bibliometrics and Journal Impact Factors, in Encyclopedia of Forensic and Legal Medicine (Second Edition), J. Payne-James and R.W. Byard, Editors. 2016, Elsevier: Oxford. p. 528-538.
13.    Nuryana, Z., G.A. Murshidi, and A. Rahman, Publication trends related to schizophrenia, mental health, and depression during COVID-19. Asian Journal of Psychiatry, 2021. 66: p. 102878.
14.    Sweileh, W.M., et al., A bibliometric analysis of literature on malaria vector resistance: (1996 - 2015). Globalization and Health, 2016. 12(1): p. 76.
15.    Wu, C.C., et al., Bibliometric Analysis of Research on the Comorbidity of Cancer and Pain. Journal of Pain Research, 2021. 14: p. 213-228.
16.    Wang, K., et al., A bibliometric analysis of 23,492 publications on rectal cancer by machine learning: basic medical research is needed. Therapeutic Advances in Gastroenterology, 2020. 13: p. 1756284820934594.,
17.    Aria, M. and C. Cuccurullo, bibliometrix: An R-tool for comprehensive science mapping analysis. Journal of Informetrics, 2017. 11(4): p. 959-975.
18.    Barr, M., Latino drug-recycling group distributes hope in a bottle--and an activist spirit. Aids, 2003. 17 Suppl 4: p. S12-3.
19.    Li, Y.Y., J. An, and S.J. Jones, A large-scale computational approach to drug repositioning. Genome Informatics. International Conference on Genome Informatics, 2006. 17(2): p. 239-47.
20.    Gordon, D.E., et al., A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature, 2020. 583(7816): p. 459-468.
21.    Zhou, Y., et al., Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 2020. 6(1): p. 14.
22.    Grewal, A., H. Kataria, and I. Dhawan, Literature search for research planning and identification of research problem. Indian Journal of Anaesthesia, 2016. 60(9): p. 635-639.
23.    Ramjith U.S., S.M., Molecular Docking Study of Novel Imidazo[2,1-b]-1,3,4 thiadiazole derivatives. Research Journal of Pharmacy and Technology, 2013. 6(6): p. 688-694.
24.    Ayyakannu Arumugam Napoleon, V.S., Molecular Docking and In-vitro anti-inflammatory evaluation of Novel Isochromen-1-one analogues from Etodolac. Research Journal of Pharmacy and Technology, 2017. 10(8): p. 2446-2450.
25.    Jeyabaskar Suganya, V.T., Mahendran Radha, Nishandhini Marimuthu., In silico Molecular Docking studies to investigate interactions of natural Camptothecin molecule with diabetic enzymes. Research Journal of Pharmacy and Technology, 2017. 10(9): p. 2917-2922.
26.    N. Habeela Jainab, M. K. Mohan Maruga Raja., In Silico Molecular Docking Studies on the Chemical Constituents of Clerodendrum phlomidis for its Cytotoxic Potential against Breast Cancer Markers. Research Journal of Pharmacy and Technology, 2018. 11(4): p. 1612-1618.
27.    Rakhi Mishra, P.S.M., Rupa Mazumder, Avijit Mazumder, Anurag Chaudhary., Computational Docking Technique for Drug Discovery: A Review. Research Journal of Pharmacy and Technology, 2021. 14(10): p. 5558-2.
28.    Anish Chittora, M.M.A.D.o.D.a.M.U.D.M.T., Discovery of Drug and Medicine Using Data Mining Techniques. Research Journal of Pharmacy and Technology, 2017. 10(12): p. 4147-4151.
29.    Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 2020. 395(10223): p. 497-506.
30.    Alaraj., M., Pharmacological repurposed agents for COVID-19. Research Journal of Pharmacy and Technology, 2022. 15(1): p.:441-6.
31.    Sheila Menon, V.B., A Review Study on the impact of COVID-19 on Mental Health in the workplace and on working people. Research Journal of Pharmacy and Technology, 2021. 14(12): p. 6725-1.
32.    Sheila Menon FBSCH, V.B., Review of the impact Covid-19 has on the Psychosocial factors affecting Well-Being. Research Journal of Pharmacy and Technology, 2021. 14(6): p. 3404-8.
33.    Chugh, H., et al., A comprehensive review on potential therapeutics interventions for COVID-19. European Journal of Pharmacology, 2021. 890: p. 173741.
34.    Irham, L.M., et al., Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents. Biochemical and Biophysical Research Communications, 2020. 529(2): p. 263-269.
35.    Gurung, A.B., et al., Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2. Journal of Infection and Public Health, 2021. 14(2): p. 227-237.
36.    Prachi Parvatikar, B.S., Sayandeep K. Das, R. Chandramouli Reddy, Shrilaxmi Bagali, Raghavendra V. Kulkarni, Aravind V. Patil, Mallanagoud S. Biradar, Kusal K. Das., Molecular Docking Identifies Novel Phytochemical Inhibitors Against SARS-COV-2 for Covid-19 Therapy. Research Journal of Pharmacy and Technology., 2022. 15(22): p. 555-8.
37.    Vipul Kumar, S.K., Manoj Kumar Jena., In silico screening of FDA approved drugs predicts the therapeutic potentials of Antibiotic drugs against the papain like protease of SARS-CoV-2. Research Journal of Pharmacy and Technology., 2021. 14(8): p. 4035-9.
38.    Bryant, A., et al., Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. American Journal of Therapeutics, 2021. 28(4).
39.    Padhy, B.M., et al., Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis. Journal of Pharmacy and Pharmaceutical Sciences, 2020. 23: p. 462-469.
40.    Beigel, J.H., et al., Remdesivir for the Treatment of Covid-19 — Final Report. New England Journal of Medicine, 2020. 383(19): p. 1813-1826.
41.    Tao, Z., et al., COVID-19 will stimulate a new coronavirus research breakthrough: a 20-year bibliometric analysis. Annals of Translational Medicine, 2020. 8(8): p. 528.
42.    Sameh Saber, A.E.K., Abdalkareem Omar Maghmomeh, Nehal A. Nouh, Ahmed M. El-Baz., COVID-19 Pandemic: current Challenges and future Perspectives. Research Journal of Pharmacy and Technology, 2022. 15(1): p. 329-7.
43.    Research collaborations bring big rewards: the world needs more. Nature, 2021. 594(7863): p. 301-302.
44.    Torres, A.G., The Importance of International Collaborations to Advance Research Endeavors. PLoS Pathogens, 2017. 13(1): p. e1006047.
45.    Matthews, K.R.W., et al., International scientific collaborative activities and barriers to them in eight societies. Accountability in Research, 2020. 27(8): p. 477-495.
46.    Savage, N., Collaboration is the key to cancer research. Nature, 2018. 556(7700): p. S1-s3.
47.    Wissing, F. and L. Bruckner-Tuderman, [Research funding for rare diseases in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2017. 60(5): p. 550-555.
48.    Akuffo, H. and T. Soop, Funding social innovation for health with research funds for development. Infectious Diseases of Poverty, 2020. 9(1): p. 120.
49.    Iorio, F., et al., Discovery of drug mode of action and drug repositioning from transcriptional responses. Proceedings of the National Academy of Sciences, 2010. 107(33): p. 14621.
50.    Cheng, F., et al., Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Computational Biology, 2012. 8(5): p. e1002503.
51.    Xu, M., et al., Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nature Medicine, 2016. 22(10): p. 1101-1107.
52.    Dyall, J., et al., Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy, 2014. 58(8): p. 4885-93.
53.    Dudley, J.T., T. Deshpande, and A.J. Butte, Exploiting drug-disease relationships for computational drug repositioning. Briefing in Bioinformatics, 2011. 12(4): p. 303-11.
54.    Rabiet, M., et al., Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. Environmental Science and Technology, 2006. 40(17): p. 5282-8.
55.    Li, J., et al., A survey of current trends in computational drug repositioning. Briefing in Bioinformatics, 2016. 17(1): p. 2-12.
56.    Roder, C. and M.J. Thomson, Auranofin: repurposing an old drug for a golden new age. Drugs in R&D, 2015. 15(1): p. 13-20.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available